Thalidomide, the notorious drug which caused horrendous birth defects in the 1950s and 1960s, is close to making a comeback as an anticancer drug. Drug firm Celgene of Warren, New Jersey, has applied to European drug authorities for permission to sell thalidomide to treat multiple myeloma, a fatal cancer of the bone marrow. In clinical trials the drug performed well against the disease. It will take Europe seven months or more to reach a verdict on the drug, which will not be prescribed to pregnant women or those considering having children.
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Life
Extinct relative of koalas discovered in Western Australia
News
Physics
The 50-year quest to create a quantum spin liquid may finally be over
Features
Technology
Backlash builds over NHS plan to hide source code from AI hacking risk
News
Health
Hantavirus: Where has the deadly cruise ship outbreak come from?
News
Popular articles
Trending 91av articles
1
Man destined to get Alzheimer’s saved by accidental heat therapy
2
Woman in cancer remission without treatment in highly unusual case
3
A lost ancient script reveals how writing as we know it really began
4
We have figured out a new way to send messages into the past
5
Honey has been used as medicine for centuries – does it really work?
6
Is consciousness more fundamental to reality than quantum physics?
7
Hantavirus: Where has the deadly cruise ship outbreak come from?
8
Prebiotic chewing gum could be helpful for gum disease
9
The 50-year quest to create a quantum spin liquid may finally be over
10
300-year-old experiment could become world's best dark matter detector
